Intravitreal bevacizumab monotherapy in myopic choroidal neovascularisation: 5-year outcomes for the PAN-American Collaborative Retina Study Group

PURPOSE: To report the long-term anatomical and visual outcomes of intravitreal bevacizumab (IVB) monotherapy in naive choroidal neovascularisation (CNV) caused by myopia. METHODS: Retrospective analysis of naive CNV secondary to myopia that underwent antivascular endothelial growth factor monothera...

Descripción completa

Guardado en:
Autores principales: Jay Chhablani, Remya Paulose, Andrés F. Lasave, Lihteh Wu, Cristián Carpentier, Maurício Maia, Silvio Lujan, Sergio Rojas, Martín Serrano, María H. Berrocal, J. Fernando Arévalo
Formato: Artículo
Lenguaje:inglés
Publicado: 2017
Materias:
Medicine
Visual acuity
Ophthalmology
Macular degeneration
Bevacizumab
Choroidal neovascularization
Geographic atrophy
Surgery
Chemotherapy
Bevacizumab administration & dosage
Adult
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Myopia complications
Retrospective Studies
Visual Acuity physiology
Choroidal Neovascularization drug therapy
Choroidal Neovascularization etiology
Choroidal Neovascularization physiopathology
Angiogenesis Inhibitors administration & dosage
Health Sciences Medicine Ophthalmology Retinal Diseases and Treatments
Health Sciences Medicine Ophthalmology Ocular Diseases and Behçet’s Syndrome
Health Sciences Medicine Radiology, Nuclear Medicine and Imaging Corneal Surgery and Treatments
Acceso en línea:Ver en el sistema de origen
Enlace permanente (DOI o Handle)
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares: Intravitreal bevacizumab monotherapy in myopic choroidal neovascularisation: 5-year outcomes for the PAN-American Collaborative Retina Study Group

Ejemplares similares